Filing Flows › Solesence (SLSN) › Q3 2025
Solesence (SLSN) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Solesence (SLSN) reported revenue of $14.6M for the third quarter 2025 (Q3 2025), -13% from a year earlier and -28% from the quarter before. Operating margin was -5.4%, net loss $1.1M (7.7% of revenue).
Solesence, Q3 2025: revenue $14.6M (-14% year over year), operating margin -5.4%, net loss $1.1M, operating cash flow −$2.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.6M | -28% | -13% |
| Operating profit | −$781K | -141% | — |
| Net earnings | −$1.1M | -142% | — |
| Operating cash flow | −$2.5M | — | — |
What changed
Revenue was $14.6M in Q3 2025, down 13% year over year and down 28% from the previous quarter. Consumer Products was the largest line at 96% of revenue. Personal Care ingredients lost $2.5M year over year (down 87%), 108% of the total change.
Gross margin was 23.1%, down 13.1 points from a year earlier. Operating costs exceeded revenue by $781K, an operating margin of -5.4%. Operating expenses grew 43% against a revenue fall of 13%. The fastest-growing cost line was SG&A (+59%). The quarter ended with a net loss of $1.1M, after a profit of $2.7M the previous quarter.
Operating cash flow was −$2.5M. Non-cash charges added back $225K of depreciation and amortization and $122K of share-based compensation. Working capital and other items used $1.7M.
Questions
What was Solesence's revenue in the third quarter 2025?
Solesence (SLSN) reported revenue of $14.6M for the third quarter 2025 (Q3 2025), -13% from a year earlier and -28% from the quarter before.
Was Solesence profitable in the third quarter 2025?
Operating loss was $781K (-5.4% of revenue) and net loss $1.1M.
Source: Solesence 10-Q on SEC EDGAR.